We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Leptin Reverses Rare Form of Diabetes

By Biotechdaily staff writers
Posted on 21 May 2002
A study has found that the hormone leptin can reverse the symptoms of a rare form of diabetes called lipodystrophy, according to researchers from the US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the University of Texas Southwestern Medical Center (Dallas, USA).

People with lipodystrophy have few or no fat cells and therefore lack leptin, a hormone produced by fat cells and stored in them. They are apt to store huge amounts of lipids in muscle or liver, to have very high levels of lipids in their blood, and to be insulin resistant. Eight of the nine female patients in the study had diabetes and were taking either insulin or a diabetes drug or a combination.

Over four months, most patients experienced significant improvements in levels of fasting glucose, or hemoglobin A1c, and triglycerides. They were able to reduce or stop their use of insulin and drugs and reported eating less after treatment. The researchers say these findings suggest that leptin reduces insulin resistance. The study was published in the February 21, 2002, issue of The New England Journal of Medicine.

"This is the first example of leptin's use in a therapeutic role in a rare form of diabetes,” said Philip Gorden, M.D., NIDDK's senior investigator of the study. "The idea is that if people have a hormone deficiency and they are given replacement hormone, they should respond.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
New
Portable POCT Blood Gas Analyzer
BD100

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
21 May 2002  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
21 May 2002  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
21 May 2002  |   BioResearch